Allosteric Modification of Oxygen Delivery by Hemoglobin
Anesth Analg 2001 92: 615-620.
[Abstract]
[Full Text]
Implications: We studied the safety and tolerance of an investigational drug, RSR13 (Allos Therapeutics, Denver, CO), in general surgery patients. This drug, which increases the amount of oxygen available to the body, was well tolerated by the 17 patients who received it. There were clinically relevant increases in serum creatinine in 3 patients, indicating a decrease in renal function, but these increases were short-lived and resolved without treatment.